Market Update Economic Events Directors Deals Commodities Prices News Market Movers

Motif Bio presents wound treatment data at San Francisco conference

Wednesday, 3rd October 2018
Bio-pharmaceutical company Motif Bio said it would present data on its wound treatment at an industry conference in San Francisco.

The data for its iclaprim treatment would be presented at IDWeek from 4-7 of October.

The data showed that iclaprim was non-inferior to vancomycin in a pooled analysis of a subgroup, the company said.

At 1:39pm: (LON:MTFB) Motif Bio Plc Ord 1p share price was -0.6p at 34.4p

Story provided by

Related Shares: Motif Bio

Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.